Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Alternate Health Corp. (OTC: AHGIF).

Full DD Report for AHGIF

You must become a subscriber to view this report.


Recent News from (OTC: AHGIF)

Alternate Health signs agreement with Liberty Health Sciences to launch Florida's first online shopping portal for medical cannabis
Alternate Health signs agreement with Liberty Health Sciences to launch Florida's first online shopping portal for medical cannabis Canada NewsWire SAN ANTONIO, TX, Sept. 4, 2018 SAN ANTONIO, TX , Sept. 4, 2018 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Com...
Source: Canada Newswire
Date: September, 04 2018 08:30
Alternate Health Signs Contract Expected to Significantly Increase Lab Business
SAN ANTONIO, TX , Aug. 7, 2018 /PRNewswire/ - Alternate Health Corp. (" Alternate Health " or the " Company ") (CSE:AHG) (OTCQB:AHGIF), an international leader in software solutions for the medical cannabis industry, announced today that the Company signed a binding contract on Augu...
Source: PR Newswire
Date: August, 07 2018 19:09
Jeff Langenbach Joins Alternate Health's Board of Directors
Jeff Langenbach Joins Alternate Health's Board of Directors Canada NewsWire SAN ANTONIO, TX, June 14, 2018 SAN ANTONIO, TX , June 14, 2018 /CNW/ - Alternate Health Corp., ( 'Alternate Health' or the 'Company' ) (CSE: AHG) (OTCQB: AHGIF), an international leader in softwar...
Source: Canada Newswire
Date: June, 14 2018 09:00
5 of Today's Biggest Marijuana Stock Losers - Friday, May 11th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Friday, May 11th including Terra Tech Corp. (OTC:TRTC) and more... Alternate Health Corp. (CSE:AHG) (OTC:AHGIF) Shares of Alternate Health Corp. dropped 5.79% today on lower than average...
Source: Daily Marijuana Observer
Date: May, 11 2018 17:47
Alternate Health CEO Updates Shareholders on Spinoff Plans
Alternate Health CEO Updates Shareholders on Spinoff Plans Canada NewsWire SAN ANTONIO, TX, May 10, 2018 SAN ANTONIO, TX , May 10, 2018 /CNW/ - Alternate Health Corp., ("Alternate Health") (CSE:AHG) (OTCQB:AHGIF), an international leader in software solutions for the medi...
Source: Canada Newswire
Date: May, 10 2018 09:00
Alternate Health Announces Plan to Uplist Blockchain Fintech Healthcare Blockchain Assets Via Corporate Spinoff
SAN ANTONIO, TX , May 1, 2018 /PRNewswire/ - Alternate Health Corp., ("Alternate Health") (CSE:AHG) (OTCQB:AHGIF), an international leader in software solutions for the medical cannabis industry, announced today a proposed plan that it believes will substantially increase shareholder valu...
Source: PR Newswire
Date: May, 01 2018 09:00
Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR
Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR Canada NewsWire SAN ANTONIO, TX, April 19, 2018 SAN ANTONIO, TX , April 19, 2018 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in ...
Source: Canada Newswire
Date: April, 19 2018 09:00
Alternate Health launches 'Zi App' - the latest innovation in fixed-exchange blockchain merchant gateways
SAN ANTONIO, TX , April 17, 2018 /PRNewswire/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in software solutions for the medical cannabis industry, today announced the launch of Zi App, an innovative mobile wallet payment p...
Source: PR Newswire
Date: April, 17 2018 09:00
Alternate Health's StatePass EMR and Cannabis Compliance Blockchain Takes on New York Market, Begins Physician Onboarding
Alternate Health's StatePass EMR and Cannabis Compliance Blockchain Takes on New York Market, Begins Physician Onboarding Canada NewsWire SAN ANTONIO, TX, April 5, 2018 SAN ANTONIO, TX , April 5, 2018 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Company") (CS...
Source: Canada Newswire
Date: April, 05 2018 09:00
Alternate Health CEO comments on undervalued stock, releases revised 2018 revenue projection
SAN ANTONIO, TX , March 7, 2018 /PRNewswire/ - Alternate Health Corp. ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated company providing software solutions and laboratory services to the medical cannabis industry, today announced the r...
Source: PR Newswire
Date: March, 07 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.392N/AN/A0
2018-12-130.400.3920.41360.3922,464
2018-12-120.410.43640.43740.4000128,500
2018-12-110.40510.40510.40510.4051100
2018-12-100.430470.3760.430470.375811,825

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1222,50028,50078.9474Short
2018-12-11100100100.0000Short
2018-12-105,50011,82546.5116Short
2018-12-072508,0003.1250Cover
2018-12-063,60019,50018.4615Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AHGIF.


About Alternate Health Corp. (OTC: AHGIF)

Logo for Alternate Health Corp. (OTC: AHGIF)

Alternate Health Corp. is an international medical cannabis company that uses best in class technology, research, education, production and laboratories to increase the awareness, understanding and utilization of cannabinoids in modern medical practices. The company is strategically positioned in all facets of the medical cannabis value chain through the innovative integration of proprietary technology and know how, acquisitions and partnerships, deep direct knowledge of and experience with improving patient outcomes, and management expertise. The company is well positioned to reinvest internal operating cash flow in its platform over the long term, thus creating an attractive investment profile for its shareholders. The company is headquartered in San Antonio and has operations in Los Angeles, and Toronto.

 

 

 

Current Management

  • Dr. Michael L. Murphy / CEO
    • Dr. Michael Murphy M.D. attended the University of Texas College of Pharmacy and the University of Texas Southwestern Medical School in Dallas, Texas. After medical school, he completed an internship in internal medicine and then a residency in anesthesiology where he served as chief resident for the Audie L. Murphy Memorial VA Hospital and the Bexar County Hospital in San Antonio, Texas. During his plus years of private practice in pain medicine, he founded, operated and eventually sold multiple different health care related ventures. These include multiple ambulatory surgical centers, doing over , cases per year, large surgical hospitals, an , square foot medical office campus, an imaging center, physical therapy center and a large medical laboratory. In addition to the medical ventures, he also helped found The Bank of San Antonio where he currently sits on the Board of Directors as well as a registered independent investment company. Dr. Murphy also spoke nationally for Medtronic Neurological and was their keynote speaker for their national sales conference. He has also taught physician practice management seminars across the country for many years. In addition, Dr. Murphy was the founder and Chairman of the Board of what is now one of the largest independent medical groups anesthesiology in the country.
  • Chris Boling / CFO
  • Jay Briggs / VP, Ops.
    • Jay Briggs has over years of experience as a business leader, entrepreneur and investor. Before accepting his position at Alternate Health, Jay led matrixed teams of software and product developers for USAA, a Fortune company, and built a reputation as an innovator and collaborator. Jay also spent several years working in the financial services industry as a Certified Financial Planner and registered investment adviser. Jay studied business in college at the undergraduate and graduate levels he most recently received his Master of Business Administration from the University of Texas at San Antonio. Jay will use his experience and business acumen to establish Alternate Health as a worldclass organization, and he is dedicated to the company s mission of bringing revolutionary management solutions to the medical cannabis industry.
  • Jade Green / VP, Sales amp Mktg.
    • After starting college at just , Jade Green studied Biochemistry and ultimately received her Bachelors of Science from the University of Florida at years old. She began her career in pharmaceutical sales before founding her own medical sales company at , where she eventually managed over employees as CEO. Jade s involvement in the medical cannabis industry began in when she invested in a company competing for one of five verticallyintegrated medical cannabis licenses authorized by the state of Florida. In addition to the capital investment, she also provided direct application support by developing a page strategic marketing plan to be included for the required portion of the license application. In , that company was awarded one of the exclusive licenses to cultivate, manufacture and dispense medical cannabis across the state, of which Jade is still an owner. In May of , Jade accepted her current position as VP of Sales and Marketing with Alternate Health Jade will use her sales and management experience to ensure the company continues its fastpaced growth and demonstrates exceptional revenue trajectories.
  • Marcelin O Neill / CCO
    • Marcelin O Neill is currently a Director and CEO of Cervantes Capital Corp., and also presently the Chief Compliance Officer of Alternate Health Corp. Ms. O Neill served as a Director of Jagercor Energy Corp. from December to May , and as Chief Financial Officer and Corporate Secretary of Jagercor, from July to May . She served as a director of Brandenburg Energy Corp. from February to February , and as Chief Financial Officer and Corporate Secretary from August to February . Ms. O Neill served as the Vice President of Corporate Affairs of Mandalay Resources Corporation from April to March , and from April until May , she served as a director of Mandalay. Since Ms. O Neill has worked with such companies as Augusta Resource Corporation, Westcoast Energy Inc., and the Lundin Group. In , Ms. O Neill graduated from the British Columbia Institute of Technology, where she studied Business Management, and has successfully completed the CSC and the CPH, both with honors. Ms. O Neill is the managing director of Accrete Consulting Inc., a company which provides corporate governance and management services to public companies. With over years of experience in public company management, Ms. O Neill brings a varied scope of knowledge to the companies with which she works.
  • Dr. Michael L. Murphy / Chairman
    • Dr. Michael Murphy M.D. attended the University of Texas College of Pharmacy and the University of Texas Southwestern Medical School in Dallas, Texas. After medical school, he completed an internship in internal medicine and then a residency in anesthesiology where he served as chief resident for the Audie L. Murphy Memorial VA Hospital and the Bexar County Hospital in San Antonio, Texas. During his plus years of private practice in pain medicine, he founded, operated and eventually sold multiple different health care related ventures. These include multiple ambulatory surgical centers, doing over , cases per year, large surgical hospitals, an , square foot medical office campus, an imaging center, physical therapy center and a large medical laboratory. In addition to the medical ventures, he also helped found The Bank of San Antonio where he currently sits on the Board of Directors as well as a registered independent investment company. Dr. Murphy also spoke nationally for Medtronic Neurological and was their keynote speaker for their national sales conference. He has also taught physician practice management seminars across the country for many years. In addition, Dr. Murphy was the founder and Chairman of the Board of what is now one of the largest independent medical groups anesthesiology in the country.
  • James Griffiths / Compensation Committee Member
    • Mr. Jim Griffiths is a current member of the Board of Trustees of the Center for Addiction and Mental Health CAMH in Toronto, Jim has a Masters in Business Administration, is a chartered accountant, and has over years of experience in the real estate development/financing industries. He was the Vice President Finance of Genstar Property Corporation and the President of First City Development Corp. He was also President and director of RealFund, Canada s first public Real Estate Investment Trust and Krystal Bond Inc. During his career, he has had responsibility for real estate asset acquisitions and sales of over billion. In addition he is very experienced in financing real estate and has negotiated and placed real estate loans in an amount exceeding . billion. Jim was a past director of Pinetree Capital Inc., the Canadian Institute of Public Real Estate Companies and was the Founding Chairman of the Association of Foreign Investors in U.S. Real Estate. He is currently a director of Allied Properties Real Estate Investment Trust, Enssolutions Group Inc., and Champion Partners and is President of KLC Capital Investment Corporation, which provides financial advisory services.
  • Michael Klipper / Independent Director, Compensation Committee Member
    • Michael Klipper, a formulary chemist, entrepreneur, author, and fundraiser is the CoFounder of Cannabinoid Science International Corp. CSI , which functions as a scientific accelerator/incubator for Cannabis related research, development, and commercialization. It s was established to develop precision made Cannabinoid based formulary compounds that can be manufactured worldwide and made available to individuals in need of healing. By collaborating with leading researchers in Biochemistry, Physics, Computer Science systems biology , and Healthcare Services Michael is a respected member of the International Cannabinoid Research Society ICRS . Michael is Director of Business Development for Transforming Medicine www.transformingmedicine.org , as well as a Founding Board Member of Voices Against Brain Cancer www.voicesagainstbraincancer.org VABC , a c committed to finding a cure for brain cancer and brain tumors by advancing scientific research and supporting patients, their families and caregivers afflicted with this devastating disease. Michael was President amp CEO of The Klipper Group, , a family of companies actively involved in formulary chemistry, developing chemical compounds, processes, and metering delivery devices. Under his leadership, the Klipper Group received the prestigious Champion Award from the United States Environmental Protection Agency EPA , highest recognition, for developing Safer Detergents for The Environment
  • Bernie Rice / Independent Director, Audit Committee Member
    • Mr. Rice has a wealth of enterprise business, experience and significant senior level relationships that are indispensable in developing many strategic partnerships. His Partner, General Wesley Clark and Mr. Rice are currently driving in a portfolio of companies with leadership capabilities in Cybersecurity, Green Energy, Medical technologies, Education and Real estate. Mr. Rice began his career with IBM in sales and held various sales leadership positions until when he entered IBM s finance fraternity. Mr. Rice s work in business case structure and portfolio analysis led him to a role as IBM s Finance Director for Application Software in . He was promoted several times such that by he was appointed Director of Finance, Planning and Administration for IBM s Southern Area. In that role, Mr. Rice was responsible for the staff functions of a billion business and he was instrumental in positioning IBM s Southeast Region as the leader in billable services. Mr. Rice became Chief Financial Officer and General Partner for the IBM Venture Capital Group in and then Vice President of Business development for IBM s Consumer Division in . Mr. Rice holds a B.A. from St. Anselm College Manchester, New Hampshire and a Masters in Business Administration in Marketing from Georgia State University. Mr. Rice also attended the IBM Presidents Program a special Executive MBA program at Harvard University.
  • Kristin Taylor / Independent Director, Audit Committee Member
    • Kristin Taylor is a technology industry thought leader and marketing strategist who has spent years developing trusted executivelevel relationships across the global technology community. Her career has been marked by marketing innovation and ideas that resulted in expanded revenue streams for her employers, ranging from the design of an industry analyst database used to map complex strategic industry relationships to the conception and development of a new hardware product that served as the catalyst for a Fortune to enter and compete in the computing market. Kristin was formerly the Vice President of Global Analyst Relations for MediaTek, a B global leader in the semiconductor industry, where she has identified new partnerships and built relationships as part of the marketing effort to build out the analyst relation function. In this role she interacts with a range of industry leaders across Europe, Asia, and the US representing media, capital markets, analysts, and corporate executives at all levels in order to determine trends and inform strategy decisions for MediaTek leadership. Prior to joining MediaTek, Kristin spent years with Qualcomm where she created the concept and led development for the new Gobi product line which was incorporated into over product offerings and spurred the creation of Qualcomm s computing division.
  • James E. Tykoliz / Independent Director, Audit Committee Member
    • Building on his degrees in Finance amp Economics from the University of Western Ontario, Mr. Tykoliz managed large accounts for pharmaceutical and packed goods companies for A.C. Nielsen Market Research before becoming an entrepreneur and building and managing dot.com operations. Mr. Tykoliz brings Alternate Health over years of sales solutions and client oriented service experience in data driven, financial service environments.

Current Share Structure

  • Market Cap: $76,914,666 - 03/20/2018
  • Issue and Outstanding: 52,681,278 - 02/01/2018
  • Float: 43,503,453 - 02/01/2018

 


Recent Filings from (OTC: AHGIF)

Management Discussion and Analysis - Third Quarter Management Discussion and Analysis - Period Ended September 30, 2017
Filing Type: Management Discussion and Analysis - Third Quarter Management Discussion and Analysis - Period EndedFiling Source: OTC Markets
Filing Date: November, 30 2017
Interim Financial Report - Third Quarter Financial Statements - Period Ended September 30, 2017
Filing Type: Interim Financial Report - Third Quarter Financial Statements - Period Ended September 30, 2017Filing Source: OTC Markets
Filing Date: November, 30 2017

 

 


Daily Technical Chart for (OTC: AHGIF)

Daily Technical Chart for (OTC: AHGIF)


Stay tuned for daily updates and more on (OTC: AHGIF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AHGIF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AHGIF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AHGIF and does not buy, sell, or trade any shares of AHGIF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/